Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease-Reference-Cited by-同舟云学术

Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease

Published:2006 Issue:12 Volume:21 Page:2078-2081
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Friedman Joseph H.,Berman Robert M.,Goetz Christopher G.,Factor Stewart A.,Ondo William G.,Wojcieszek Joanne,Carson William H.,Marcus Ronald N.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference27 articles.

1. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease

2. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

3. Mental symptoms in Parkinson's disease are important contributors to caregiver distress

4. Risk factors for nursing home placement in advanced Parkinson's disease

5. Predictors of Nursing Home Placement in Parkinson's Disease: A Population-Based, Prospective Study

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D₄R Antagonists;ACS Chemical Neuroscience;2024-06-07

2. Clearing the Fog: A Review of Antipsychotics for Parkinson's-Related Hallucinations: A Focus on Pimavanserin, Quetiapine and Clozapine;Journal of Integrative Neuroscience;2024-04-12

3. Efficacy of Trihexyphenidyl on Apraxia of Eyelid Opening in Parkinsonism: A Case Report;Cureus;2024-03-15

4. Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease;Journal of Parkinson's Disease;2023-11-03

5. 5-HT_1A agonists for levodopa-induced dyskinesia in Parkinson's disease;Neurodegenerative Disease Management;2023-04